Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Columbus Venture Partners
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2017 Founded
Registers and programsofficial lists and records that name the company
Legal entity VIRALGEN VECTOR CORE S.L.U its site
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
Capsida Biotherapeutics is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies…
Skyline Therapeutics is a fully integrated gene therapy company dedicated to the discovery, development and delivery of innovative…
Forge BiologicsSeries B $120M · 5 yr ago • Founded 2020 • 201-500 employees • 14 roles
Forge Biologics is accelerating gene therapy manufacturing: high-yield AAV manufacturing, a world-class cGMP facility, and seamless support.
SomagenetixFounded 2019 • 51-200 employees
Ex-vivo gene therapy for phagocyte disorders. Somagenetix develops lentiviral HSC programs, starting with CGD—advancing safe, durable…
Spur Therapeutics is a clinical-stage biotech that optimizes every component of its gene therapy candidates to change the course of…

Overview

At Viralgen, we're proud to be known for just one thing: Being a world leader in AAV-based gene therapy manufacturing.. We're all in on AAV; it's all we do, all day, every day.